Weill Cornell Medical College
New York, 10065, United States
NCT Number: NCT02755883
This randomized controlled trial will evaluate, among 54 stage early stage lung cancer patients, whether a behavioral intervention versus an educational Control group results in improved function at 6-months.
Looking for future studies?
Notify Me18 year–110 year
All sexes
Interventional
Not applicable
New York, 10065, United States
This is a two arm randomized controlled trial that will evaluate, among 54 stage 1 non-small cell lung cancer patients, whether induction of positive affect vs. an educational Control group, results in improved function as assessed by the 6-minute Walk Test. Our primary outcome will be a within-patient change in the 6-Minute Walk Test at 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be randomized to a physical activity goal and will receive the positive affect component.
Subjects will be randomized to a physical activity goal and will receive the educational component.
Time frame: 1 month to 6 months
Time frame: 1 month to 6 months
Pulmonary function test
Time frame: 1 month to 6 months
Disease-specific quality of life
Time frame: 1 month to 6 months
Time frame: 1 month to 6 months
Pulmonary function test
Weill Medical College of Cornell University
Other
Strides For Life I: A Randomized Controlled Trial of Induction of Positive Affect to Increase Physical Activity in Early Stage Lung Cancer Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06003335
Behavior, Cancer-related Cognitive Impairment
Hong Kong
View Trial DetailsNCT07591376
Behavior, Lung Cancer
Vejle, Denmark
View Trial DetailsNCT03724331
Behavior, Bronchial Neoplasms
Omaha, Nebraska, United States
View Trial DetailsNCT02493114
Behavior, Exercise Capacity
Genk, Belgium
View Trial Details